Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The best biotech stocks to own now
Marketwatch
Thursday, January 13, 2011 - 12:28pm
tags:
Cerus, Curis, CompuGen, Impax, Spectrum Pharmaceuticals
Xoma and Elan: A Tale of Two Mismanaged Biotech Companies
Seeking Alpha
Thursday, January 13, 2011 - 12:22pm
tags:
Xoma, Elan
Merck Pipeline Setback: Big Pharma Losers
TheStreet.com
Thursday, January 13, 2011 - 12:20pm
tags:
Merck, Vorapaxar
Percocet, Vicodin Face Limits on Acetaminophen Dose
Bloomberg
Thursday, January 13, 2011 - 12:10pm
tags:
percocet, Vicodin, acetaminophen, painkillers, Abbott Laboratories, Endo
Merck tumbles on drug study woes
Marketwatch
Thursday, January 13, 2011 - 12:04pm
tags:
Merck, Vorapaxar, blood thinners
Investing in drugs that promote longevity
Marketwatch
Thursday, January 13, 2011 - 12:01pm
tags:
rapamycin, Rapamune, Pfizer, Wyeth, longevity
6 High Yield Pharmaceutical Companies: Do They Justify the Risk?
Seeking Alpha
Thursday, January 13, 2011 - 11:57am
tags:
GSK, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer
The FDA approvals of 2010
Fierce Biotech
Wednesday, January 12, 2011 - 7:24pm
tags:
Watson Pharmaceuticals, Theratechnologies, Shire, Savient, Sanofi, Roche, Orphan Europe, Novo Nordisk, Novartis, Merz, JNJ, HRA Pharma, Genzyme, Forest Labs, FDA, Eisai, Dainippon Sumitomo, Chemiche Fabrik Kresussler, Boehringer Ingelheim, Bayer, Auxilium, Amgen, Allergan, Acorda Therapeutics
Biogen expects MS sales hit from Gilenya
Fierce Pharma
Wednesday, January 12, 2011 - 7:17pm
tags:
Biogen Idec, Gilenya, MS, multiple sclerosis
Lilly’s Solpura Isn’t Ready for Approval, Panel Says
Bloomberg
Wednesday, January 12, 2011 - 7:15pm
tags:
Eli Lilly, Solpura, advisory panels
Sanofi’s bid for Genzyme gets EU OK
Bizjournals.com
Wednesday, January 12, 2011 - 7:13pm
tags:
Genzyme, Sanofi, Europe, M&A
What Shorts Might Be Watching at Forest Laboratories
Motley Fool
Wednesday, January 12, 2011 - 12:34pm
tags:
Forest Labs
Allos reports $11.7 million in 4Q revenue
Yahoo/AP
Wednesday, January 12, 2011 - 12:34pm
tags:
earnings, Allos
Oregon Sues Johnson & Johnson Over ‘Phantom Recall’
Bloomberg
Wednesday, January 12, 2011 - 12:33pm
tags:
Oregon, JNJ, recalls, lawsuits
Lilly says brain swelling seen in Alzheimer's study patient
Reuters
Wednesday, January 12, 2011 - 12:24pm
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Sanofi, Genzyme Chiefs Say Talks Are Advancing on Fee
Bloomberg
Wednesday, January 12, 2011 - 12:18pm
tags:
Genzyme, Sanofi, M&A
Is XOMA a Turnaround Stock?
Seeking Alpha
Wednesday, January 12, 2011 - 12:17pm
tags:
Xoma
Illumina Strikes Back In Gene Machine Wars
Forbes
Wednesday, January 12, 2011 - 12:14pm
tags:
DNA sequencing, Illumina
Bayer ‘Determined’ to Guard Rights After Humira Ruling
Bloomberg
Wednesday, January 12, 2011 - 12:10pm
tags:
Bayer, Humira, Abbott Laboratories, arthritis
Is Biogen Idec's Stock a Bargain by the Numbers?
Motley Fool
Wednesday, January 12, 2011 - 12:08pm
tags:
Biogen Idec

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.